Docusign's Q3 Net Income Jumps 34%, But YTD Falls on Tax Shift

Ticker: DOCU · Form: 10-Q · Filed: 2025-12-05T00:00:00.000Z

Sentiment: mixed

Topics: Software, E-signature, Intelligent Agreement Management, Cloud Computing, Financial Results, AI Integration, Subscription Revenue

Related Tickers: DOCU, ADBE, MSFT, CRM

TL;DR

**DOCU's Q3 looks solid with revenue and profit growth, but don't get fooled by the year-to-date net income dip – it's a tax story, not an operational one.**

AI Summary

Docusign, Inc. reported a significant increase in net income for the three months ended October 31, 2025, reaching $83.725 million, up from $62.423 million in the same period of 2024, representing a 34.13% increase. However, net income for the nine months ended October 31, 2025, dramatically decreased to $218.782 million from $984.394 million in 2024, primarily due to a substantial deferred income tax benefit in the prior year. Total revenue for the quarter grew to $818.350 million from $754.820 million year-over-year, a 8.41% increase, driven by subscription revenue which rose to $800.958 million from $734.693 million. Operating expenses increased to $562.449 million for the quarter, up from $539.253 million, with research and development seeing a notable rise to $167.626 million from $151.101 million. The company's strategic outlook emphasizes its Intelligent Agreement Management (IAM) platform, eSignature solution, and contract lifecycle management (CLM) solution, leveraging AI capabilities to automate workflows and transform agreement data. Risks include global macroeconomic conditions, competition, and the ability to integrate generative AI successfully.

Why It Matters

Docusign's Q3 performance, marked by a 34% net income increase and 8.41% revenue growth, signals continued demand for its core eSignature and IAM solutions, which is crucial for investor confidence in a competitive market. The significant year-to-date net income drop, primarily due to a non-recurring deferred tax benefit in 2024, requires careful investor scrutiny to differentiate operational performance from accounting adjustments. For employees, the sustained revenue growth and increased R&D spending suggest stability and investment in future product development, particularly in AI. Customers benefit from Docusign's focus on AI-powered IAM, enhancing productivity and agreement management, which could solidify its market position against rivals like Adobe.

Risk Assessment

Risk Level: medium — The company faces medium risk due to its reliance on global macroeconomic conditions, including volatile interest rates and foreign exchange rates, as stated in the 'Note Regarding Forward-Looking Statements'. Additionally, the ability to compete effectively in an evolving market and successfully incorporate generative AI into products are significant challenges, as highlighted by the emphasis on 'our ability to successfully incorporate generative artificial intelligence ("AI") into our existing and future products and to successfully deploy them'.

Analyst Insight

Investors should look beyond the year-over-year net income decline for the nine months, as it's largely an accounting anomaly from a prior tax benefit. Focus on the strong Q3 subscription revenue growth of 8.41% and the company's strategic investments in AI and Intelligent Agreement Management (IAM) as potential drivers for future growth, but remain aware of competitive pressures.

Financial Highlights

revenue
$818,350,000
total Assets
$3,982,039,000
net Income
$83,725,000
cash Position
$583,291,000
revenue Growth
+8.41%

Revenue Breakdown

SegmentRevenueGrowth
Subscription$800,958,000+8.4%
Professional services and other$17,392,000-13.6%

Key Numbers

Key Players & Entities

FAQ

What were Docusign's key revenue figures for the quarter ended October 31, 2025?

Docusign reported total revenue of $818.350 million for the three months ended October 31, 2025, an increase from $754.820 million in the prior year. Subscription revenue, the primary driver, was $800.958 million for the quarter.

How did Docusign's net income change in Q3 2025 compared to the previous year?

Docusign's net income for the three months ended October 31, 2025, was $83.725 million, a significant increase from $62.423 million in the same period of 2024. This represents a 34.13% year-over-year growth for the quarter.

Why did Docusign's year-to-date net income decrease so sharply in 2025?

Docusign's net income for the nine months ended October 31, 2025, was $218.782 million, a substantial decrease from $984.394 million in the same period of 2024. This decline is primarily attributed to a large deferred income tax benefit of $804.340 million recorded in the prior year's period.

What is Docusign's strategic focus for future growth?

Docusign's strategic focus is on its Intelligent Agreement Management (IAM) platform, its leading eSignature solution, and contract lifecycle management (CLM) solution. The company aims to leverage AI capabilities to automate agreement workflows, uncover actionable insights, and enhance the customer experience.

What are the main risks Docusign highlights in its 10-Q filing?

Docusign highlights risks such as global macroeconomic conditions, including inflation and volatile interest rates, intense competition in an evolving market, and the ability to successfully incorporate generative artificial intelligence (AI) into its products. Data breaches and the ability to manage growth are also noted risks.

How much cash did Docusign generate from operating activities in the first nine months of 2025?

Docusign generated $787.786 million in net cash from operating activities for the nine months ended October 31, 2025. This is an increase from $709.360 million generated in the same period of 2024.

What was Docusign's stock-based compensation expense for the nine months ended October 31, 2025?

Docusign's total stock-based compensation expense for the nine months ended October 31, 2025, was $466.776 million. This figure was slightly higher than the $460.388 million reported for the same period in 2024.

Did Docusign repurchase any common stock during the nine months ended October 31, 2025?

Yes, Docusign repurchased common stock totaling $600.002 million during the nine months ended October 31, 2025. This is an increase from the $521.803 million in repurchases during the same period in 2024.

What is Docusign's current number of outstanding common shares?

As of November 30, 2025, Docusign had 200,272,740 shares of common stock outstanding. This is a decrease from 202,477,000 shares outstanding as of January 31, 2025.

How does Docusign plan to use AI in its products?

Docusign plans to incorporate generative artificial intelligence (AI) into its existing and future products to enhance its Intelligent Agreement Management (IAM) platform. This will enable organizations to automate agreement workflows, uncover actionable insights from agreement data, and simplify business processes securely.

Risk Factors

Industry Context

Docusign operates in the rapidly evolving digital transformation and workflow automation market, with a strong focus on agreement management. The competitive landscape includes established players and emerging technology companies, particularly those integrating AI. Key industry trends involve the increasing adoption of cloud-based solutions, the demand for enhanced security and compliance, and the drive towards AI-powered automation to improve efficiency and extract value from agreement data.

Regulatory Implications

Docusign must navigate a complex web of global data privacy regulations, such as GDPR and CCPA, which impact how customer data is handled and secured. Changes in these regulations or potential non-compliance could lead to significant fines and reputational damage. Furthermore, evolving e-signature laws and digital trust standards require continuous monitoring and adaptation to ensure legal validity and customer confidence.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Glossary

Intelligent Agreement Management (IAM)
A platform that aims to automate and streamline the entire lifecycle of agreements, from creation to execution and management, often incorporating AI and other advanced technologies. (Docusign's strategic focus is on its IAM platform, indicating its importance for future growth and product development.)
eSignature
A legal process that electronically authenticates a document or a signature, serving as a digital equivalent to a handwritten signature. (Docusign's core offering, which continues to be a significant revenue driver.)
Contract Lifecycle Management (CLM)
Software solutions that help organizations manage contracts from initial request and authoring through negotiation, execution, and ongoing management and compliance. (A key component of Docusign's broader IAM strategy, complementing its eSignature capabilities.)
Deferred income tax benefit
A reduction in the income tax expense recognized in the financial statements, often due to specific tax regulations, carryforwards, or changes in tax law that result in a future tax saving. (The significant deferred income tax benefit in the prior year (YTD 2024) explains the large year-over-year decrease in net income for the nine-month period.)
Contract assets—current
Represents the company's right to consideration in exchange for goods or services that have been transferred to a customer, where the right is conditional on something other than the passage of time. (Part of current assets, reflecting revenue recognized before billing or cash collection.)
Contract liabilities—current
Represents obligations to transfer goods or services to a customer for which the company has received consideration from the customer, or an amount of consideration that is unconditional. (Primarily represents deferred revenue, indicating future revenue to be recognized from customer payments received in advance.)

Year-Over-Year Comparison

Compared to the prior year's reporting period, Docusign shows a healthy 8.41% increase in total revenue for Q3 2025, reaching $818.4M, primarily driven by subscription growth. While quarterly net income saw a robust 34.13% increase, the year-to-date net income figure is significantly lower due to a substantial deferred income tax benefit in the prior year. Operating expenses, particularly R&D, have increased, reflecting investment in innovation. Key balance sheet items show a decrease in cash and cash equivalents and a slight reduction in shares outstanding, alongside an increase in common stock repurchases.

Filing Stats: 4,540 words · 18 min read · ~15 pages · Grade level 18.5 · Accepted 2025-12-05 16:57:27

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) Condensed Consolidated Balance Sheets as of October 31, 2025 and January 31, 2025 4 Condensed Consolidated Statements of Operations and Comprehensive Income for the Three and Nine Months Ended October 31, 2025 and 2024 5 Condensed Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended October 31, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows for the Nine Months Ended October 31, 2025 and 2024 8 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 36 Item 4.

Controls and Procedures

Controls and Procedures 37

- OTHER INFORMATION

PART II - OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 38 Item 1A.

Risk Factors

Risk Factors 38 Item 2 . Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 63 Item 5. Other Information 64 Item 6. Exhibits 64 Exhibit Index 65

Signatures

Signatures 66 Docusign, Inc. | 2026 Form 10-Q | 2 NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve substantial risk and uncertainties. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future operating results and financial position, our business strategy and plans, market growth and trends, our product strategy and anticipated future products and capabilities, our objectives for future operations, and the impact of such assumptions on our financial condition and results of operations are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about: our expectations regarding global macro-economic conditions, including the effects of inflation, volatile interest rates or foreign exchange rates, and market volatility on the global economy; our inability to accurately estimate our market opportunity; our ability to compete effectively in an evolving and competitive market; the impact of any interruptions or delays in performance of our technical infrastructure, or data breaches, cyberattacks or other fraudulent or malicious activity attempting

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS DOCUSIGN, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in thousands, except per share data) October 31, 2025 January 31, 2025 Assets Current assets Cash and cash equivalents $ 583,291 $ 648,623 Investments—current 256,580 314,924 Accounts receivable, net of allowance for doubtful accounts of $ 8,697 and $ 8,828 as of October 31, 2025 and January 31, 2025 354,978 429,582 Contract assets—current 8,978 13,764 Prepaid expenses and other current assets 103,328 82,368 Total current assets 1,307,155 1,489,261 Investments—noncurrent 208,529 134,105 Property and equipment, net 343,636 299,370 Operating lease right-of-use assets 133,183 109,630 Goodwill 457,247 454,477 Intangible assets, net 60,816 76,388 Deferred contract acquisition costs—noncurrent 462,552 467,201 Deferred tax assets—noncurrent 838,694 840,470 Other assets—noncurrent 170,227 141,803 Total assets $ 3,982,039 $ 4,012,705 Liabilities and Equity Current liabilities Accounts payable $ 22,482 $ 30,697 Accrued expenses and other current liabilities 119,841 99,579 Accrued compensation 180,982 227,115 Contract liabilities—current 1,444,599 1,455,442 Operating lease liabilities—current 15,840 19,077 Total current liabilities 1,783,744 1,831,910 Contract liabilities—noncurrent 28,027 21,523 Operating lease liabilities—noncurrent 134,533 105,350 Deferred tax liability—noncurrent 18,497 20,596 Other liabilities—noncurrent 35,717 30,634 Total liabilities 2,000,518 2,010,013 Commitments and contingencies ( Note 7 ) Stockholders' equity Preferred stock, $ 0.0001 par value; 10,000 shares authorized, 0 shares issued and outstanding as of October 31, 2025 and January 31, 2025 — — Common stock, $ 0.0001 par value; 500,000 shares authorized, 200,297 shares outstanding as of October 31, 2025; 500,000 shares authorized, 202,477 shares outstanding as of January 31, 2025 20 20 Treasury stock, at cost: 37 shares as of October

View on Read The Filing